Lifestyle intervention

Lifestyle intervention has been studied in 173 papers since 2014: 57 trials and 30 observational studies in people, 1 in animals, 76 reviews; 102 in the past year. The newest story, Oct 23, 2026: “Adding sleep support did not improve glucose control”.

Intervention

173 papers study it142 findingsUpdated

Research on it is growing 39% faster than aging research as a whole: 17 papers in the latest year counted

8 new papers in 30 daysSee all 171 papers on lifestyle intervention

At a glance

Human studies report improved physical function with lifestyle intervention, replicated by independent labs, and a human trial reports lower multimorbidity risk. Independent labs also report reduced depressive symptoms and body weight, while cognitive and telomere outcomes differ across human studies. Some papers declare company ties.

142 findings in 72 papers from 2014 to 2026, 19 of them since April 2026

Independent labs found the same change in people. 52 independent labs in 19 countries; 11 trials, 6 about aging.

“Randomization to lifestyle intervention was associated with 57% lower odds of progression to low ABI (adjusted OR=0.43, 95% CI 0.24-0.77, p=0.005) relative to placebo”
Long-Term Effects of Metformin and Lifestyle Interventions on Ankle-Brachial Index in the Diabetes Prevention Program Outcomes Study (DPPOS)ADA Scientific Sessions 2026 abstract2026doi:10.2337/db26-1418-p

9 of its findings point the other way.

Humans: replicated by independent labs. Cells and mice: a single group. Worms or flies: nothing yet.
  • 52 independent labs in 19 countries
  • 9 findings against
  • 11 trials, 6 about aging
  • Funders: National Institutes of Health and others
  • 16 of 128 findings with company ties
  • Human trial55
  • Humans30
  • Animals1
  • In silico2

28 studies gave lifestyle intervention to people and measured what changed.

What changedDesignPeopleSource

up: Increases daily step count+523 steps/day (95% CI 229, 818) in IGT

no change: Has no effect on daily step countmean 71 steps/day (95% CI −429, 571)

down: Decreases 2-hour post-challenge glucosemean −0.5 mmol/l (95% CI −0.9, 0.0)

Randomized trialup to 48 months2,150 peopleBoth63-65 yearsParticipants at risk of type 2 diabetesDiabetologia, Sep 14, 2026

no change: Has no effect on lung function

Randomized trial19.0 ± 0.8 years1,888 peopleBoth68.2 ± 9.3 yearsOlder adults; at risk for diabetesRespiratory medicine, Aug 4, 2026

up: Improves cognitive functionp = 0.03

Trial6-month30 peopleBothmean age 63.0 yearsOlder adults; Patient cohortsActa diabetologica, Jul 22, 2026

down: Lowers the risk of multimorbidityHR 0.79 (95% CI 0.68-0.93)

Treated cohort3 years1,173 peopleBothadults, median age 74 yearsOlder adults; participants followed from DPP into DPPOSJAMA, Jun 15, 2026

down: Decreases senescence-associated beta-galactosidase-36% (P < 0.05, n = 9)

Trial10-week9 people≥65 yearsOlder adults; obesityADA Scientific Sessions 2026 abstract, Jun 5, 2026

What did studies of lifestyle intervention find?

94

Studies of lifestyle intervention measured 94 outcomes; the most studied are body weight (11 studies), cognitive function (5) and inflammation (3).

Body weight

downin humans11−9.8%

11 studies
  1. Lifestyle intervention decreases body weight in humans (–0.79 kg vs. –0.19 kg).

    “Among all participants, those in the intervention group lost more weight than those in the control group (average weight change: –0.79 kg vs. –0.19 kg, P = 0.001) and had a greater reduction in waist circumference (–1.70 cm vs. –0.85 cm, P = 0.002) during the first visit.”

    Human trial4 yearsfemalesn = 1,180

    Lifestyle intervention reduces type 2 diabetes incidence among young women with previous gestational diabetes: A randomized controlled trial

    Chinese medical journal

  2. Lifestyle intervention decreases body weight in humans.

    “women in the intervention group, compared with the control group, lost more weight”

    Human trial4-yearfemalesn = 1,180

    Lifestyle intervention reduces type 2 diabetes incidence among young women with previous gestational diabetes: A randomized controlled trial

    Chinese medical journal

  3. Lifestyle intervention decreases body weight in humans (prediabetes with overweight/obesity, maintainers vs non-responders) (mean difference -4.0 kg; 95% CI -5.8, -2.2 kg).

    “compared with non-responders, maintainers achieved greater weight loss (mean difference -4.0 kg; 95% CI -5.8, -2.2 kg)”

    Human trialprediabetes with overweight/obesity, maintainers vs non-responders3 years

    Enduring improvements in hepatic insulin sensitivity predict sustained remission of prediabetes during a 3-year lifestyle intervention: results from the PREVIEW multinational diabetes prevention trial

    Metabolism: clinical and experimental

  4. Lifestyle intervention decreases body weight in rejoiners compared to previous intervention (weight: -1.5% vs. -3.5%, VAT: -7.2% vs. -33.3%, deep SAT: -4.0% vs. -31.9%, superficial SAT: -3.3% vs. -25.4% (all FDR < 0.05)).

    “In response to T2, rejoiners exhibited attenuated improvements compared to those achieved during their previous T1 intervention (weight: -1.5% vs. -3.5%; VAT: -7.2% vs. -33.3%”

    Human trialin rejoiners compared to previous interventiontrial 2

    How effective is rejoining a long-term weight loss program? The 5- and 10-year MRI-assessed Follow Interventions Trial (FIT) project

    BMC medicine

  5. Lifestyle intervention decreases body weight in humans (obesity and type 2 diabetes; Study I) (-9.8%).

    “Body weight decreased by 9.8% in Study I and 5.3% in Study II”

    Human trialobesity and type 2 diabetes; Study I1 year

    Cardiometabolic Gains Unrelated to Weight Loss-Adjusted Body Fat or Distribution Changes in Adults With and Without Diabetes

    Obesity (Silver Spring, Md.)

  6. Lifestyle intervention decreases body weight in humans (whole group) (-6.6 ± 2.9 kg).

    “Patients lost 6.6 ± 2.9 kg, with a BMI change of −2.62 ± 1.1 Kg/m2, a waist circumference reduction of 6.5 ± 6.9 cm, an average fat mass reduction of 1.27 ± 1.68%, and fat-free mass increase of 1.3 ± 1.63%.”

    Human trialwhole group12 monthsn = 20

    Telomere Length and Mitochondrial DNA Copy Number Variations in Patients with Obesity: Effect of Diet-Induced Weight Loss-A Pilot Study

    Nutrients

  7. Lifestyle intervention decreases body weight in lower than median baseline TL group compared to higher baseline TL group (−8.1 ± 2.7 vs. −6.1 ± 4.6 Kg, p = 0.03).

    “greater weight loss (−8.1 ± 2.7 vs. −6.1 ± 4.6 Kg, respectively, p = 0.03)”

    Human trialin lower than median baseline TL group compared to higher baseline TL group1-year

    Telomere Length and Mitochondrial DNA Copy Number Variations in Patients with Obesity: Effect of Diet-Induced Weight Loss-A Pilot Study

    Nutrients

  8. Lifestyle intervention decreases body weight in humans (middle-aged and elderly men with NAFLD).

    “After the 2-year periodic intervention, body weight, abdominal circumference, ALT, TCH, LDL-C and HDL-C decreased in the test group.”

    Human trialmiddle-aged and elderly men with NAFLDcounseling on diet and exercise every 3 months by phone2 yearsmalesn = 280

    Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial

    Scientific reports

  9. Lifestyle intervention is linked with lower body weight in Japanese individuals with obesity disease.

    “Mean weight and BMI numerically decreased from baseline to follow-up across groups.”

    Humansin Japanese individuals with obesity disease846 to 1211 daysn = 782

    Real-World Weight Loss Outcomes by Obesity Management Approaches in Japan: Descriptive Findings from the J-ORBIT Database Linked to Electronic Medical Records (J-ORBIT2)

    Diabetes therapy : research, treatment and education of diabetes and related disorders

  10. Lifestyle intervention is linked with lower body weight in humans (combined with tirzepatide or semaglutide treatment).

    “Lifestyle interventions further enhanced weight reduction, most notably with tirzepatide.”

    Humanscombined with tirzepatide or semaglutide treatmentn = 100

    Efficacy and Safety of Tirzepatide and Semaglutide for Obesity Management: A Real-World Comparison

    Cureus

All 13

Cognitive function

upin humans4no changein humans1

5 studies
  1. Lifestyle intervention improves cognitive function in humans (p = 0.03).

    “Significant improvements were observed in global cognition (p = 0.03), verbal memory (p = 0.008), and executive function (p = 0.005).”

    Human trial6-monthn = 30

    Improving cognition through lifestyle-induced remission of type 2 diabetes: findings from DIABEPIC-2

    Acta diabetologica

  2. Lifestyle intervention improves cognitive function in humans (older adults at risk of AD).

    “After the intervention, older adults improved significantly in learning and memory, with MCI benefiting the most.”

    Human trialolder adults at risk of ADsmartphone app-aided lifestyle medicine programone-monthn = 158

    Memory improvements among older adults with memory complaints and mild cognitive impairment after lifestyle intervention: An uncontrolled trial

    Journal of Alzheimer's disease : JAD

  3. Lifestyle intervention showed no clear effect on cognitive function in humans.

    “No differences were found between women and men in the effectiveness of the intervention on cognitive performance.”

    Human trial

    Who Benefited the Most? Effectiveness of a Lifestyle Intervention Against Cognitive Decline in Older Women and Men - Secondary Analysis of the AgeWell.de-trial

    The journal of prevention of Alzheimer's disease

  4. Lifestyle intervention improves cognitive function in humans (SMD = 0.18).

    “Combined interventions yielded small, but statistically significant cognitive benefits (overall cognition: SMD = 0.18; memory: SMD = 0.10; executive function: SMD = 0.09).”

    Reviewn = 12,286

    Exercise- and dietary pattern-based lifestyle interventions and neurocognitive function in adults: a Bayesian multilevel network and dose-response meta-analysis

    Journal of neurology

  5. Lifestyle intervention improves cognitive function in humans (overweight or obesity).

    “Also, lifestyle intervention can reverse cognitive dysfunction, especially dieting, to encourage weight loss.”

    Reviewoverweight or obesity

    Inflammatory Pathways in Overweight and Obese Persons as a Potential Mechanism for Cognitive Impairment and Earlier Onset Alzeihmer's Dementia in the General Population: A Narrative Review

    Biomedicines

Inflammation

downin humans3

3 studies
  1. Lifestyle intervention decreases inflammation in humans (obesity and T2D).

    “intervention was associated with downregulation of inflammatory and endoplasmic reticulum (ER) stress transcriptional programs”

    Human trialobesity and T2Dcirculating immune cells6 monthsn = 9

    Lifestyle intervention is associated with attenuation of ER stress/inflammation and enhancement of naive immune cell identity in older adults with metabolic disease

    bioRxiv : the preprint server for biologyPreprint

  2. Lifestyle intervention inhibits inflammation in humans.

    “downregulated immune-related pathways, including the complement system, inflammation, cholesterol transport and coagulation”

    Human trial13-week

    Blood Proteomic Biomarkers indicate reduced system and tissue level inflammation responses to The GOTO Lifestyle Intervention in Older Adults

    medRxivPreprint

  3. Lifestyle intervention decreases inflammation in humans.

    “These interventions can be integrated within a healthy lifestyle to reduce senescence and inflammation and delay the consequences of aging.”

    Review

    Lifestyle interventions to delay senescence

    Biomedical journal

More on Inflammation

Physical function

upin humans3

3 studies
  1. Lifestyle intervention improves physical function in humans (obesity and T2D).

    “Participants showed substantial weight loss (~7%) alongside improvements in glycemic control, insulin sensitivity, and physical performance.”

    Human trialobesity and T2D6 monthsn = 9

    Lifestyle intervention is associated with attenuation of ER stress/inflammation and enhancement of naive immune cell identity in older adults with metabolic disease

    bioRxiv : the preprint server for biologyPreprint

  2. Lifestyle intervention improves physical function in humans.

    “with positive effects on a number of relevant outcomes, including physical function and cardiovascular parameters”

    Review

    Treatment of obesity in older persons-A systematic review

    Obesity reviews : an official journal of the International Association for the Study of Obesity

  3. Lifestyle intervention improves physical function in humans (obesity).

    “The literature consistently confirmed benefits of lifestyle interventions to physical function assessed at the clinical level.”

    Reviewobesity

    Obesity and physical frailty in older adults: a scoping review of lifestyle intervention trials

    Journal of the American Medical Directors Association

Physical activity

upin humans1no changein humans1

2 studies
  1. Lifestyle intervention increases physical activity in humans (22.4% vs. 14.3%).

    “meeting the physical activity goal [103/460 (22.4%) vs. 67/470 (14.3%), P = 0.001] compared with the control group”

    Human trial4 years

    Lifestyle intervention reduces type 2 diabetes incidence among young women with previous gestational diabetes: A randomized controlled trial

    Chinese medical journal

  2. Lifestyle intervention increases physical activity in humans.

    “increased physical activity and consumed more fiber”

    Human trial4-yearfemalesn = 1,180

    Lifestyle intervention reduces type 2 diabetes incidence among young women with previous gestational diabetes: A randomized controlled trial

    Chinese medical journal

  3. Lifestyle intervention showed no clear effect on physical activity in humans.

    “No significant changes in fruit intake and physical activity levels were observed among groups.”

    Human trialfemalesn = 405

    Lifestyle Outcomes Six and Twelve Months After Hypertensive Disorders of Pregnancy: A Blood Pressure Postpartum Sub-Study

    Nutrients

Insulin sensitivity

upin humans1upin silico1

2 studies
  1. Lifestyle intervention increases insulin sensitivity in humans (obesity and type 2 diabetes; Study I) (Clamp-derived insulin sensitivity +50%; HOMA-IR -26%).

    “Clamp-derived insulin sensitivity increased by 50% (Study I), and HOMA-IR decreased by 26% in both studies.”

    Human trialobesity and type 2 diabetes; Study I1 year

    Cardiometabolic Gains Unrelated to Weight Loss-Adjusted Body Fat or Distribution Changes in Adults With and Without Diabetes

    Obesity (Silver Spring, Md.)

  2. Lifestyle intervention improves insulin sensitivity in silico (impaired glucose tolerance) (Insulin-dependent glucose clearance declined 2.1%/year with intervention versus 8.1%/year due to disease progression).

    “translated to a much slower deterioration of the first-phase insulin secretion and insulin sensitivity.”

    In silicoimpaired glucose tolerancen = 101

    Mathematical diabetes disease progression modeling in the integrated glucose-insulin model among individuals with impaired glucose tolerance from the Finnish Diabetes Prevention Study

    bioRxivPreprint

Depressive symptoms

downin humans2

2 studies
  1. Lifestyle intervention decreases depressive symptoms in humans.

    “The AgeWell.de intervention was able to improve depressive symptoms in women”

    Human trialfemalesn = 433

    Who Benefited the Most? Effectiveness of a Lifestyle Intervention Against Cognitive Decline in Older Women and Men - Secondary Analysis of the AgeWell.de-trial

    The journal of prevention of Alzheimer's disease

  2. Lifestyle intervention decreases depressive symptoms in humans.

    “The results demonstrated significant indirect effects from intervention receipt to decreased depressive symptoms via increased activity frequency and activity significance.”

    Human trial6 monthsn = 460

    Understanding the Mechanisms of Change in a Lifestyle Intervention for Older Adults

    The Gerontologist

More on Depressive symptoms

Telomere length

upin humans1no changein humans1

1 study
  1. Lifestyle intervention increases telomere length in the L-TL group.

    “In the L-TL group, the TL significantly increased at T12, while no significant change was observed in the H-TL group.”

    Human trialin the L-TL group12 months

    Telomere Length and Mitochondrial DNA Copy Number Variations in Patients with Obesity: Effect of Diet-Induced Weight Loss-A Pilot Study

    Nutrients

  2. Lifestyle intervention showed no clear effect on telomere length in humans (whole group).

    “TL and the mtDNA copy number from baseline (T0) to follow-up (T12) were not significantly different in the whole group.”

    Human trialwhole group12 monthsn = 20

    Telomere Length and Mitochondrial DNA Copy Number Variations in Patients with Obesity: Effect of Diet-Induced Weight Loss-A Pilot Study

    Nutrients

  3. Lifestyle intervention increases telomere length in lower than median baseline TL group compared to higher baseline TL group (+0.57 ± 1.23 vs. −2.15 ± 1.13 kbp, p = 0.04).

    “At T12, the L-TL group when compared to H-TL showed TL elongation (respectively, +0.57 ± 1.23 vs. −2.15 ± 1.13 kbp, p = 0.04)”

    Human trialin lower than median baseline TL group compared to higher baseline TL group1-year

    Telomere Length and Mitochondrial DNA Copy Number Variations in Patients with Obesity: Effect of Diet-Induced Weight Loss-A Pilot Study

    Nutrients

More on Telomere length

2-hour post-challenge glucose

downin humans1

1 study
  1. Lifestyle intervention decreases 2-hour post-challenge glucose in the IFG+IGT group (mean −0.5 mmol/l (95% CI −0.9, 0.0)).

    “The intervention improved 2 h post-challenge glucose levels in the IFG+IGT group only (mean −0.5 mmol/l; 95% CI −0.9, 0.0).”

    Human trialin the IFG+IGT groupup to 48 monthsn = 362

    Differential physical activity responses to diabetes risk reduction interventions according to prediabetes phenotype in at-risk individuals: pooled analysis from three randomised controlled trials

    Diabetologia

  2. Lifestyle intervention decreases 2-hour post-challenge glucose in individuals with both IFG and IGT (mean -0.5 mmol/l (95% CI -0.9, 0.0)).

    “The intervention improved 2 h post-challenge glucose levels in the IFG+IGT group only (mean -0.5 mmol/l; 95% CI -0.9, 0.0).”

    Human trialin individuals with both IFG and IGTup to 48 months

    Differential physical activity responses to diabetes risk reduction interventions according to prediabetes phenotype in at-risk individuals: pooled analysis from three randomised controlled trials

    Diabetologia

More on 2-hour post-challenge glucose

Daily step count

no changein humans1upin humans1

1 study
  1. Lifestyle intervention showed no clear effect on daily step count in the IFG group (mean 71 steps/day (95% CI −429, 571)).

    “The intervention increased the mean number of steps/day relative to usual care by 247 (95% CI 4, 491) in the normoglycaemia group, 523 (95% CI 229, 818) in the IGT group, and 808 (95% CI 402, 1213) in the IFG+IGT group, but not in the IFG group (mean 71; 95% CI −429, 571).”

    Human trialin the IFG groupup to 48 monthsn = 273

    Differential physical activity responses to diabetes risk reduction interventions according to prediabetes phenotype in at-risk individuals: pooled analysis from three randomised controlled trials

    Diabetologia

  2. Lifestyle intervention increases daily step count in normoglycaemia, IGT, and IFG+IGT groups (+523 steps/day (95% CI 229, 818) in IGT).

    “The intervention increased the mean number of steps/day relative to usual care by 247 (95% CI 4, 491) in the normoglycaemia group, 523 (95% CI 229, 818) in the IGT group, and 808 (95% CI 402, 1213) in the IFG+IGT group, but not in the IFG group (mean 71; 95% CI −429, 571).”

    Human trialin normoglycaemia, IGT, and IFG+IGT groupsup to 48 months

    Differential physical activity responses to diabetes risk reduction interventions according to prediabetes phenotype in at-risk individuals: pooled analysis from three randomised controlled trials

    Diabetologia

Daily step count

no changein humans1upin humans1

1 study
  1. Lifestyle intervention showed no clear effect on daily step count in individuals with impaired fasting glucose (IFG) (mean 71 steps/day (95% CI -429, 571)).

    “but not in the IFG group (mean 71; 95% CI -429, 571).”

    Human trialin individuals with impaired fasting glucose (IFG)up to 48 months

    Differential physical activity responses to diabetes risk reduction interventions according to prediabetes phenotype in at-risk individuals: pooled analysis from three randomised controlled trials

    Diabetologia

  2. Lifestyle intervention increases daily step count in individuals with impaired glucose tolerance (IGT) (523 steps/day (95% CI 229, 818)).

    “The intervention increased the mean number of steps/day relative to usual care by 247 (95% CI 4, 491) in the normoglycaemia group, 523 (95% CI 229, 818) in the IGT group”

    Human trialin individuals with impaired glucose tolerance (IGT)up to 48 months

    Differential physical activity responses to diabetes risk reduction interventions according to prediabetes phenotype in at-risk individuals: pooled analysis from three randomised controlled trials

    Diabetologia

More on Daily step count

Physical health

upin humans1no changein humans1

1 study
  1. Lifestyle intervention improves physical health in humans (as-treated analysis with inverse probability of censoring weights) (B = 2.28, 95% CI [2.48, 2.75]).

    “AST analysis showed improvements in both the mental (B = 0.77, 95% CI [0.49, 1.04]) and physical (B = 2.28, 95% CI [2.48, 2.75]) composites.”

    Human trialas-treated analysis with inverse probability of censoring weightsn = 424

    The Effectiveness of Lifestyle Interventions for Older Adults According to Publicly Available Data

    GSA 2025 abstract

  2. Lifestyle intervention showed no clear effect on physical health in humans (intention-to-treat analysis) (B = 0.71, 95% CI [-0.02, 0.03]).

    “no significant effect on the physical composite (B = 0.71, 95% CI [-0.02, 0.03]).”

    Human trialintention-to-treat analysisn = 424

    The Effectiveness of Lifestyle Interventions for Older Adults According to Publicly Available Data

    GSA 2025 abstract

Oxidative stress and ROS signaling

downin human cells1downin humans1

1 study
  1. Lifestyle intervention decreases oxidative stress and ROS signaling in humans.

    “It can also be observed that at T1, the percentage changes in plasma values of markers of oxidation, such as TBARS, IsoP and 8OHdG compared to T0, were significantly greater in control group versus LSP group ( C).”

    Human trialthree months

    Beneficial effects of a combined lifestyle intervention for older people in a long-term-care facility on redox balance and endothelial function

    Heliyon

  2. Lifestyle intervention decreases oxidative stress and ROS signaling in human cells (HUVEC treated with plasma from LSP group vs T0).

    “Finally, at T1, in HUVEC treated with plasma from LSP group only we found an increase of the mitochondrial membrane potential and a reduction of ROS and MitoROS release”

    CellsHUVEC treated with plasma from LSP group vs T0

    Beneficial effects of a combined lifestyle intervention for older people in a long-term-care facility on redox balance and endothelial function

    Heliyon

More on Oxidative stress and ROS signaling

8-hydroxy-2'-deoxyguanosine

downin humans1

1 study
  1. Lifestyle intervention decreases 8-hydroxy-2'-deoxyguanosine in humans (-62 % vs -20 %).

    “Instead, the levels of 8OHdG were reduced both in LSP group and control group, at T1, although at a lesser extent in control group (−20 % in control group: from 46 ng/ml of T0 to 36 ng/ml of T1;-62 % in LSP group: from 49 ng/ml of T0 to 18 ng/ml of T1; p < 0.05; E, F”

    Human trialthree months

    Beneficial effects of a combined lifestyle intervention for older people in a long-term-care facility on redox balance and endothelial function

    Heliyon

  2. Lifestyle intervention decreases 8-hydroxy-2'-deoxyguanosine in humans.

    “Also, plasma levels of 8OHdG were lower in LSP group vs control.”

    Human trial3 monthsn = 54

    Beneficial effects of a combined lifestyle intervention for older people in a long-term-care facility on redox balance and endothelial function

    Heliyon

More on 8-hydroxy-2'-deoxyguanosine

Body mass index

downin humans1

1 study
  1. Lifestyle intervention decreases body mass index in young adulthood overweight (YAO) trajectory (β = -0.52, p = 0.018).

    “Our results showed that YAO and ECO trajectories in the intervention group were concomitant with lower BMI levels than in the control group, with the highest estimated effect in the latter (β=-0.52 and p = 0.018; β= -1.48 and p < 0.001, respectively).”

    Human trialin young adulthood overweight (YAO) trajectorymedian follow-up of 16.1 yearsn = 780

    Effectiveness of a practical multi-setting lifestyle intervention on the main BMI trajectories from childhood to young adulthood: A community-based trial

    BMC public health

  2. Lifestyle intervention decreases body mass index in humans (young adulthood overweight trajectory) (β=-0.52, p=0.018).

    “Only Young adulthood overweight and Early childhood increasing obesity were affected by the intervention and were concomitant with lower BMI levels than the control group”

    Human trialyoung adulthood overweight trajectorymedian 16.1 years

    Effectiveness of a practical multi-setting lifestyle intervention on the main BMI trajectories from childhood to young adulthood: A community-based trial

    BMC public health

More on Body mass index

All 94

What is lifestyle intervention linked with?

6

Studies link lifestyle intervention with 6 measures, most often type 2 diabetes (4 studies).

Type 2 diabetes

downin humans4HR 0.54

4 studies
  1. Lifestyle intervention lowers the risk of type 2 diabetes in humans (HR 0.54, 95% CI: 0.33-0.90).

    “the cumulative incidence of diabetes was 46% lower in the intervention group than in the control group (HR 0.54, 95% CI: 0.33-0.90”

    Human trial4 yearsfemalesn = 1,180

    Lifestyle intervention reduces type 2 diabetes incidence among young women with previous gestational diabetes: A randomized controlled trial

    Chinese medical journal

  2. Lifestyle intervention lowers the risk of type 2 diabetes in humans (-46% (95% CI 10-67%)).

    “The lifestyle intervention reduced the incidence of diabetes by 46% (95% confidence interval: 10-67%) using the OGTT to diagnose diabetes”

    Human trial4-yearfemalesn = 1,180

    Lifestyle intervention reduces type 2 diabetes incidence among young women with previous gestational diabetes: A randomized controlled trial

    Chinese medical journal

  3. Lifestyle intervention lowers the risk of type 2 diabetes in humans (high 1h-PG group compared with IGR group) (reduced by 80% (37 - 96 %)).

    “Risk of T2D during 12-years follow-up was reduced by 80% (37 - 96 %, p = 0.005) in the high 1h-PG group compared to the IGR group.”

    Human trialhigh 1h-PG group compared with IGR group12-year follow-upn = 318

    High One-Hour Post-load Plasma Glucose Is an Intermediate Condition between NGR and IGR

    ADA Scientific Sessions 2025 abstract

  4. Lifestyle intervention lowers the risk of type 2 diabetes in individuals with prediabetes.

    “T2D can be prevented in those with prediabetes by lifestyle intervention, with or without medication.”

    Reviewin individuals with prediabetes

    Prevention of type 2 diabetes in India and China

    Metabolism: clinical and experimental

  5. Lifestyle intervention lowers the risk of type 2 diabetes in humans.

    “Lifestyle intervention (dietary energy reduction and lower glycemic load plus structured exercise) is first-line and cost-effective; DPP/DPPOS show substantial diabetes risk reduction.”

    Review

    Insulin Resistance: Implications for Nutrition, Oncology, and Diabetes Management-An Updated Review

    Saudi Journal of Medicine and Public Health

More on Type 2 diabetes

Multimorbidity

downin humans1HR 0.79

1 study
  1. Lifestyle intervention lowers the risk of multimorbidity in humans (HR 0.79 (95% CI 0.68-0.93)).

    “The risk of multimorbidity was lower among lifestyle compared with placebo participants (hazard ratio [HR], 0.79; 95% CI, 0.68-0.93)”

    Human trialversus placebo, after adjustment for relevant covariates; participants followed from DPP into DPPOSn = 1,173

    Lifestyle and Metformin Interventions and Risk of Multimorbidity in Adults With Prediabetes

    JAMA

More on Multimorbidity

Cardiovascular disease

downin humans1

1 study
  1. Lifestyle intervention lowers the risk of cardiovascular disease in humans.

    “Modifications in lifestyle, such as quitting smoking, regular physical activity, following a heart-healthy diet plan, and getting adequate sleep, can significantly reduce the risk of CVD.”

    Review

    A narrative review of precision and ethical considerations in cardiovascular health: CRISPR-Cas9, telemedicine, and lifestyle interventions

    Frontiers in public health

More on Cardiovascular disease

Net weight loss after semaglutide discontinuation

upin humans1

1 study
  1. Lifestyle intervention is associated with net weight loss after semaglutide discontinuation in humans (12 months after semaglutide discontinuation) (-5.8 ± 0.5% vs -3.3 ± 0.3%).

    “At 12 months following discontinuation, net weight loss remained greater among LI participants (-5.8 ± 0.5%) compared to nonparticipants (-3.3 ± 0.3%, p<0.01)”

    Humans12 months after semaglutide discontinuation12 months following discontinuationn = 2,403

    Weight Loss Maintenance following Semaglutide Discontinuation—The Role of Concurrent Lifestyle Intervention

    ADA Scientific Sessions 2025 abstract

More on Net weight loss after semaglutide discontinuation

Body weight

downin humans1

1 study
  1. Lifestyle intervention is associated with body weight in humans during semaglutide treatment, before discontinuation (-8.3% vs -7.4% weight change).

    “Individuals with concurrent LI achieved greater weight loss before semaglutide discontinuation (-8.3% vs. -7.4%, p<0.001).”

    Humansduring semaglutide treatment, before discontinuationn = 2,403

    Weight Loss Maintenance following Semaglutide Discontinuation—The Role of Concurrent Lifestyle Intervention

    ADA Scientific Sessions 2025 abstract

More on Body weight

Telomere length

downin humans1

1 study
  1. Lifestyle intervention is associated with telomere length in humans (P = 0.02 vs controls; P = 0.003 vs medically treated; F(2,54) = 4.98, P = 0.01 overall).

    “Telomeres were shorter in the GDM lifestyle intervention group compared to both controls (P = 0.02) and medically treated pregnancies (P = 0.003).”

    Humansmale placenta only; compared with controls and with metformin and/or insulin treated pregnanciesplacentamales

    Metformin and insulin treatment prevent placental telomere attrition in boys exposed to maternal diabetes

    PloS one

More on Telomere length

Has lifestyle intervention been tested in people?

6 of 11 about aging

Yes: 57 trials and 30 observational studies in people have been published.

Trial sponsors

Funding

32 grants since 2016

National Institute on Aging$25.8MNational Heart, Lung, and Blood Institute$3.6MNational Institute of Diabetes and Digestive and Kidney Diseases$4.2M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human trials report improved Personal-MetaboHealth in at-risk participants and increased steps with impaired glucose tolerance, but not impaired fasting glucose. One human study reports increased weight loss in men at the contemplation stage, but no overall effect after insufficient initial weight loss.

  2. Summary written from the findings.

Latest

Dec 2025: 7Jan 2026: 15Feb 2026: 10Mar 2026: 9Apr 2026: 6May 2026: 4Jun 2026: 9Jul 2026: 4Aug 2026: 12Sep 2026: 12Oct 2026: 7Nov 2026: 499 papers in 12 months
Nursing Research

Adding sleep support did not improve glucose control

An eight-week randomized trial in 196 adults with prediabetes and short sleep found no significant added glucose or weight-loss benefit over lifestyle support alone.An eight-week randomized trial in 196 adults with prediabetes and short sleep found no significant added glucose or weight-loss benefit over lifestyle support alone.

Randomized trial · 196 peopleInterventions

See all 171 papers on lifestyle intervention